CHOP Research Institute

Center for Applied Genomics

Today's Research Becomes Tomorrows Cure

Aevi Genomic Medicine reports a trial investigating a personalized drug for attention deficit hyperactivity disorder.
Article by: GenomeWeb; April 21, 2017